OTC/SmallCap IRW
Sims Limited Announces the Appointment of Victoria Binns to Board of Directors; Jim Thompson to Retire
NEW YORK, Oct. 18, 2021 /PRNewswire/ -- Sims Limited, a global leader in metal recycling and data center IT circularity, and an emerging leader in municipal recycling and renewable energy, announces the appointment of Victoria "Vicky" Binns as an independent non-executive director to the Board of...
2021-10-18 17:00
2925
Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine
Agreement Expands on the Companies' Collaboration for the Preclinical Development of Potential Anti-Cancer Therapies TORRANCE, Calif., Oct. 12, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle ce...
2021-10-12 20:23
2281
SmartKem, Inc. Announces Joint Development Agreement with RiTdisplay
MANCHESTER, United Kingdom, Oct. 12, 2021 /PRNewswire/ -- SmartKem, Inc. (OTCQB: SMTK), a company seeking to reshape the world of electronics with a revolutionary new organic semiconductor platform that enables a new generation of displays, announced that it has entered into a joint development a...
2021-10-12 19:00
2096
SmartKem To Present At The LD Micro Main Event On October 12th At 11:30 Am PST
MANCHESTER, England, Oct. 12, 2021 /PRNewswire/ -- SmartKem, Inc. (OTCQB: SMTK), a company seeking to reshape the world of electronics with a revolutionary semiconductor platform that enables a new generation of displays, sensors, and logic, announced today its CEO,Ian Jenks, will present at the ...
2021-10-12 03:17
5478
CLSA：Fosun's Outstanding Performance on ESG, Solidifying Leadership in Sustainable Development
HONG KONG, Oct. 8, 2021 /PRNewswire/ -- CLSA has published the first ESG deep-dived research report on Fosun International (HK 656). The report has pointed out that Fosun's ESG mission is clear: actively address the growing demand for corporate sustainability. Fosun has a rigorous structure and p...
2021-10-08 13:42
23237
Resonant Inc. Expands Strategic Partnership with Murata Manufacturing Co., Ltd., the World's Leading RF Module and Filter Provider
Resonant's XBAR® Technology to be Leveraged Across Additional Bands AUSTIN, Texas, Oct. 7, 2021 /PRNewswire/ -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, has expan...
2021-10-07 11:09
8663
Sasol announces lead role in feasibility study for the Boegoebaai Green Hydrogen Project
JOHANNESBURG, Oct. 7, 2021 /PRNewswire/ -- The Boegoebaai "green hydrogen" development has been designated a Strategic Integrated Project (SIP) in the South African National Development Plan and is located in the Namakwa Special Economic Zone (SEZ). The project's location and classification as a ...
2021-10-07 03:11
7801
NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference
SHELTON, Conn., Oct. 5, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, presented an update of its Pan-Coronavirus COVID-19 Drug Development Program at t...
2021-10-05 18:45
10914
/DISREGARD RELEASE: Infineon Technologies AG/
We are advised by Infineon Technologies AG that journalists and other readers should disregard the news release, "Infineon launches SLS37 V2X Hardware Security Module to safeguard vehicle to everything communication" issued onOct. 4, 2021 by Infineon Technologies AG as the release was transmitted...
2021-10-05 16:10
11827
Infineon launches SLS37 V2X Hardware Security Module to safeguard vehicle to everything communication
MUNICH, Oct. 4, 2021 /PRNewswire/ -- To provide the highest level of protection, Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is launching the SLS37 V2X hardware security module (HSM), a plug-and-play security solution for vehicle to everything communication (V2X). The SLS37 V2X HSM is base...
2021-10-04 11:03
7019
BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission
VANCOUVER, BC, Sept. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys" or "Company"), announced today that it has started its plannedin vivo animal toxicology study of CoviDTH in parallel with the preparation of an IND submission. Under the terms ...
2021-09-28 20:00
6375
BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins
- Potential for superior tolerability to mRNA and Adenovirus Vector vaccines - Production Agreement signed with Millipore-Sigma for SARS-CoV-2 Vaccine Supply VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), a...
2021-09-23 15:00
5609
Sasol commits to net zero ambition by 2050, triples 2030 GHG emission reduction targets
JOHANNESBURG, Sept. 22, 2021 /PRNewswire/ -- Sasol Limited (Sasol) today announced its updated strategy that commits it to be at net zero emissions by 2050. This is in line with Sasol's commitment to accelerate its transition to a low carbon world in support of the objectives of the Paris Agreeme...
2021-09-22 22:07
7370
Arçelik joins the UN Global Compact CFO Taskforce to align finance and sustainability for real world change
ISTANBUL, Sept. 22, 2021 /PRNewswire/ -- Arçelik A.Ş. (IST: ARCLK) ("Arçelik"), the global leading consumer durables and electronics manufacturer, has announced that Polat Şen, the Chief Financial Officer (CFO) of Arçelik has joined the UN Global Compact CFO Taskforce. With 60 members across 23 ...
2021-09-22 18:48
6007
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug
SHELTON, Conn., Sept. 22, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today on the significant advantages gained by remdesivir encapsulation ...
2021-09-22 18:45
5142
BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone
VANCOUVER, British Columbia, Sept. 17, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that cancer vaccine manufacturing partner Bio Elpida inLyon, France, has reached major milestones in the development of the bioproduction proce...
2021-09-17 15:00
5069
Sasol, Haldor Topsøe expand G2LTM licensing collaboration to grow sustainable synthetic fuels and chemicals globally
JOHANNESBURG, Sept. 15, 2021 /PRNewswire/ -- Haldor Topsøe and Sasol have expanded collaboration to jointly license and develop their technologies for sustainable liquid fuels and chemicals production through Fischer-Tropsch (FT) technology. Sasol and Topsøe currently offer integrated end-to-end...
2021-09-15 20:23
7382
10,000 green hydrogen generators per month: groundbreaking for Enapter electrolyser mass production in North Rhine-Westphalia
Acting, not talking. - Enapter Campus enables mass production of AEM Electrolysers and serves as a blueprint for further Enapter production facilities worldwide - Electrolyser production, warehouse storage and offices, as well as research and development laboratories will be built over 82,000...
2021-09-15 04:25
4853
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs
VANCOUVER, BC, Sept. 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320, the company's COVID-19 vaccine candida...
2021-09-14 15:00
5458
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a nov...
2021-09-13 19:00
5863
Week's Top Stories
Most Reposted
PARKROYAL COLLECTION MARINA BAY IS THE FIRST HOTEL IN SINGAPORE TO ATTAIN THREE PRESTIGIOUS SUSTAINABILITY CERTIFICATIONS
[Picked up by 323 media titles]
2024-12-19 13:41
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 309 media titles]
2024-12-20 16:25
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
[Picked up by 308 media titles]
2024-12-19 17:56
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 306 media titles]
2024-12-20 18:11
XTransfer and OCBC Jointly Announce Comprehensive Partnership
[Picked up by 263 media titles]
2024-12-23 17:36
Most Read
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
2024-12-20 18:11
9900
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
2024-12-19 17:56
9528
